See more : Imerys S.A. (IMYSY) Income Statement Analysis – Financial Results
Complete financial analysis of Nuveen California Select Tax-Free Income Portfolio (NXC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Nuveen California Select Tax-Free Income Portfolio, a leading company in the Asset Management – Income industry within the Financial Services sector.
- Bolt Projects Holdings Inc (BSLKW) Income Statement Analysis – Financial Results
- Nameson Holdings Limited (1982.HK) Income Statement Analysis – Financial Results
- Stealth BioTherapeutics Corp (MITO) Income Statement Analysis – Financial Results
- Louisiana-Pacific Corporation (LPX) Income Statement Analysis – Financial Results
- Killi Resources Limited (KLI.AX) Income Statement Analysis – Financial Results
Nuveen California Select Tax-Free Income Portfolio (NXC)
Industry: Asset Management - Income
Sector: Financial Services
Website: https://www.nuveen.com/CEF/Product/Overview.aspx?FundCode=NXC&refsrc=vu_nuveen.com/nxc
About Nuveen California Select Tax-Free Income Portfolio
Nuveen California Select Tax-Free Income Portfolio is a closed-ended fixed income mutual fund launched by Nuveen Investments Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of California. The fund invests in the securities of companies that operate across diversified sectors. It primarily invests in municipal bonds. The fund employs fundamental analysis to create its portfolio. It benchmarks the performance of its portfolio against Barclays Capital California Municipal Bond Index and S&P California Municipal Bond Index. Nuveen California Select Tax-Free Income Portfolio was formed on June 19, 1992 and is domiciled in the United States.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.70M | -5.90M | 3.54M | 5.95M | 4.80M | 4.66M | 4.30M | 4.03M | 4.52M | 4.48M | 4.59M | 4.69M | 0.00 |
Cost of Revenue | 0.00 | 267.74K | 291.94K | 2.32M | 1.07M | 938.57K | 300.16K | 298.11K | 296.67K | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 3.70M | -6.16M | 3.25M | 3.62M | 3.73M | 3.72M | 4.00M | 3.73M | 4.23M | 4.48M | 4.59M | 4.69M | 0.00 |
Gross Profit Ratio | 100.00% | 104.54% | 91.75% | 60.92% | 77.65% | 79.85% | 93.02% | 92.60% | 93.44% | 100.00% | 100.00% | 100.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 87.04K | 92.50K | 350.37K | 92.50K | 97.51K | 269.08K | 106.05K | 359.37K | 352.04K | 355.80K | 347.55K | 348.17K | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 87.04K | 92.50K | 350.37K | 92.50K | 97.51K | 269.08K | 106.05K | 359.37K | 352.04K | 355.80K | 347.55K | 348.17K | 0.00 |
Other Expenses | 0.00 | -7.57M | -4.64M | 2.27K | 2.41K | 2.73K | 3.09K | 0.00 | 986.13K | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 1.40M | 94.82K | 4.89M | 94.77K | 99.92K | 271.81K | 109.14K | 3.93M | -986.13K | 4.85M | 4.32M | 3.67M | 0.00 |
Cost & Expenses | 1.40M | 94.82K | 4.93M | 2.23M | 973.61K | 666.76K | 109.14K | 3.80M | -689.46K | 4.85M | 4.32M | 3.67M | 0.00 |
Interest Income | 3.70M | 3.55M | 367.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 1.80K | 44.00 | 366.55 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.26K | 9.00K | 0.00 |
Depreciation & Amortization | 2.81M | -3.23M | -3.15M | -3.27M | -3.38M | -3.20M | -3.59M | -3.80M | -4.03M | -4.12M | -4.24M | -4.34M | 0.00 |
EBITDA | 5.10M | -5.99M | -1.39M | 2.58M | 1.33M | 1.18M | 0.00 | -3.57M | 1.19M | 5.21M | -3.98M | 4.01M | 0.00 |
EBITDA Ratio | 137.99% | 101.61% | -39.31% | 43.41% | 27.66% | 25.41% | 97.46% | 5.75% | 115.24% | 116.28% | -86.63% | 85.54% | 0.00% |
Operating Income | 2.29M | -5.99M | -1.39M | 3.27M | 3.38M | 3.20M | 4.19M | 231.34K | 5.21M | 4.12M | 4.24M | 4.34M | 0.00 |
Operating Income Ratio | 62.01% | 101.61% | -39.31% | 54.99% | 70.26% | 68.75% | 97.46% | 5.75% | 115.24% | 92.05% | 92.43% | 92.57% | 0.00% |
Total Other Income/Expenses | 2.81M | -5.72M | -4.54M | 0.00 | 0.00 | 0.00 | 0.00 | -3.57M | -9.00 | 0.00 | -3.98M | 0.00 | 0.00 |
Income Before Tax | 5.10M | -5.99M | -1.39M | 5.85M | 4.70M | 4.39M | 4.19M | 231.34K | 5.21M | 9.33M | 265.72K | 8.35M | 0.00 |
Income Before Tax Ratio | 137.94% | 101.61% | -39.32% | 98.41% | 97.92% | 94.17% | 97.46% | 5.75% | 115.24% | 208.33% | 5.79% | 178.12% | 0.00% |
Income Tax Expense | 0.00 | 3.23M | -4.54M | 2.58M | 1.33M | 1.18M | 3.59M | -3.57M | 1.19M | 5.21M | -3.98M | 4.00M | 0.00 |
Net Income | 5.10M | -5.99M | -1.39M | 5.85M | 4.70M | 4.39M | 4.19M | 231.34K | 5.21M | 9.33M | 265.72K | 8.35M | 0.00 |
Net Income Ratio | 137.94% | 101.61% | -39.32% | 98.41% | 97.92% | 94.17% | 97.46% | 5.75% | 115.24% | 208.33% | 5.79% | 178.12% | 0.00% |
EPS | 0.80 | -0.94 | -0.22 | 0.92 | 0.74 | 0.69 | 0.66 | 0.04 | 0.83 | 1.49 | 0.04 | 1.33 | 0.00 |
EPS Diluted | 0.80 | -0.94 | -0.22 | 0.92 | 0.74 | 0.69 | 0.66 | 0.04 | 0.83 | 1.49 | 0.04 | 1.33 | 0.00 |
Weighted Avg Shares Out | 6.36M | 6.36M | 6.36M | 6.36M | 6.35M | 6.35M | 6.35M | 6.29M | 6.28M | 6.28M | 6.27M | 6.27M | 6.27M |
Weighted Avg Shares Out (Dil) | 6.36M | 6.36M | 6.36M | 6.36M | 6.35M | 6.36M | 6.35M | 6.29M | 6.28M | 6.28M | 6.27M | 6.27M | 6.27M |
Nuveen Closed-End Funds Declare Distributions and Updates to Distribution Policies
Weekly Closed-End Fund Roundup: January 8, 2023
Weekly Closed-End Fund Roundup: VFL Tender Results (December 18, 2022)
Weekly Closed-End Fund Roundup: June 21, 2020
The Reopening Killed The V-Shaped Recovery
Source: https://incomestatements.info
Category: Stock Reports